Cortexyme (CRTX) stock forecast for 2022 – 2027

Are you interested in Cortexyme, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CRTX stock price in 2022-2027. Is CRTX a good long term stock? When should I take profit in Cortexyme stock? Buy or sell stock? Will CRTX stock price go up? What are analysts’ forecasts for CRTX stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CRTX stock returns are also predicted based on historical data.

According to our research, CRTX stock is a awesome long-term investment. CRTX share price has been in a bull cycle for the past year. Cortexyme, Inc. stock trend is positive.

Cortexyme company info

Industry Biotechnology
Address 269 East Grand Avenue, South San Francisco, CA, 94080, United States
Website https://www.cortexyme.com

Forecasting

52 Week High: 32.8241 USD
52 Week Low: 4.59 USD
1 Year Forecast: 17.26 USD
5 Year Forecast: 40.199 USD

Agilent Technologies info

Market Cap: 181.66M
52 Week Change: -30.158%
52 Week High: 121.98 USD
52 Week Low: 5.6 USD
Beta: 1.13296
50 Day Moving Average: 11.56
90 Day Moving Average: 12.332
200 Day Moving Average: 49.55
Resistance Level: 6.80437
Pivot Point: 6.06914
Support Level: 5.42626
Enterprise Value: 234,411,584
Forward P/E: -2.29
Forward EPS: -2.61
Profit Margin: 0.00%
Shares Outstanding: 29,877,600
EBITDA: -2.69
Held Percent Institutions: 59.03%
PEG Ratio (5Y): -0.25
Trailing EPS: -2.94

Cortexyme stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Cortexyme Stock Forecast for 2022

March 2022 14 10.89 -22.21%
April 2022 10.89 13.86 27.27%
May 2022 14 14 0%
June 2022 13.72 26.52 93.29%
July 2022 26 22.54 -13.31%
August 2022 24.48 30.69 25.37%
September 2022 31 32.67 5.39%
October 2022 31.68 7.07 -77.68%
November 2022 5.94 5.1 -14.14%
December 2022 6.06 9.18 51.49%

Cortexyme Stock Forecast for 2023

January 2023 8.16 22.77 179.04%
February 2023 23.76 22.44 -5.56%
March 2023 21 17.82 -15.14%
April 2023 17 20.58 21.06%
May 2023 20.79 21 1.01%
June 2023 22 33.66 53%
July 2023 32 30 -6.25%
August 2023 31.31 37.24 18.94%
September 2023 38.38 40 4.22%
October 2023 39.78 13.72 -65.51%
November 2023 13.13 12.74 -2.97%
December 2023 13.13 15 14.24%

Cortexyme Stock Forecast for 2024

January 2024 15.3 28.71 87.65%
February 2024 31.31 27.44 -12.36%
March 2024 28.28 25.5 -9.83%
April 2024 24.24 27.44 13.2%
May 2024 26.73 29 8.49%
June 2024 27.44 39.78 44.97%
July 2024 38.22 36.63 -4.16%
August 2024 38.22 44.55 16.56%
September 2024 43.12 46.92 8.81%
October 2024 45.08 21 -53.42%
November 2024 20 19.6 -2%
December 2024 18.81 22 16.96%

Cortexyme Stock Forecast for 2025

January 2025 21.42 37.62 75.63%
February 2025 39.6 35.28 -10.91%
March 2025 33 31.31 -5.12%
April 2025 31 34.34 10.77%
May 2025 34.3 34.3 0%
June 2025 35.7 45.54 27.56%
July 2025 46.46 45.45 -2.17%
August 2025 44.1 52.52 19.09%
September 2025 52.02 54.06 3.92%
October 2025 53 27.72 -47.7%
November 2025 25.74 26.73 3.85%
December 2025 25.74 28 8.78%

Cortexyme Stock Forecast for 2026

January 2026 28.71 43 49.77%
February 2026 46 43.86 -4.65%
March 2026 40.18 37.24 -7.32%
April 2026 37.74 42.42 12.4%
May 2026 41.16 42.84 4.08%
June 2026 41.58 52.47 26.19%
July 2026 51.94 52.52 1.12%
August 2026 53 58.58 10.53%
September 2026 56.84 59.4 4.5%
October 2026 60 36.72 -38.8%
November 2026 32.67 33.66 3.03%
December 2026 33 35.64 8%

Cortexyme Stock Forecast for 2027

January 2027 35.64 40 12.23%